Načítá se...

Inhibition of FGF‐FGFR and VEGF‐VEGFR signalling in cancer treatment

The sites of targeted therapy are limited and need to be expanded. The FGF‐FGFR signalling plays pivotal roles in the oncogenic process, and FGF/FGFR inhibitors are a promising method to treat FGFR‐altered tumours. The VEGF‐VEGFR signalling is the most crucial pathway to induce angiogenesis, and inh...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cell Prolif
Hlavní autoři: Liu, Guihong, Chen, Tao, Ding, Zhenyu, Wang, Yang, Wei, Yuquan, Wei, Xiawei
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley and Sons Inc. 2021
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8016646/
https://ncbi.nlm.nih.gov/pubmed/33655556
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cpr.13009
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!